BCIQ Profiles

Company Profile Report

CMS’s new CKD payment models could be mixed bag for drug companies

A set of five different payment models announced by the Centers for Medicare & Medicaid Services for patients with chronic kidney disease or end-stage renal disease could be a boon for companies that have taken a renewed interest in new treatments for renal disease. However,

Read the full 458 word article

How to gain access

Continue reading with a
two-week free trial.